Skip Nav Destination
Issue Archive
February 8 2018
Table of Contents
BLOOD COMMENTARIES
PERSPECTIVE
BLOOD SPOTLIGHT
LYMPHOID NEOPLASIA
CD38-bispecific antibody pretargeted radioimmunotherapy for multiple myeloma and other B-cell malignancies
Damian J. Green,Shyril O’Steen,Yukang Lin,Melissa L. Comstock,Aimee L. Kenoyer,Donald K. Hamlin,D. Scott Wilbur,Darrell R. Fisher,Margaret Nartea,Mark D. Hylarides,Ajay K. Gopal,Theodore A. Gooley,Johnnie J. Orozco,Brian G. Till,Kelly D. Orcutt,K. Dane Wittrup,Oliver W. Press
MYELOID NEOPLASIA
Physiological Srsf2 P95H expression causes impaired hematopoietic stem cell functions and aberrant RNA splicing in mice
Ayana Kon,Satoshi Yamazaki,Yasuhito Nannya,Keisuke Kataoka,Yasunori Ota,Masahiro Marshall Nakagawa,Kenichi Yoshida,Yusuke Shiozawa,Maiko Morita,Tetsuichi Yoshizato,Masashi Sanada,Manabu Nakayama,Haruhiko Koseki,Hiromitsu Nakauchi,Seishi Ogawa
Mutant calreticulin knockin mice develop thrombocytosis and myelofibrosis without a stem cell self-renewal advantage
Juan Li,Daniel Prins,Hyun Jung Park,Jacob Grinfeld,Carlos Gonzalez-Arias,Stephen Loughran,Oliver M. Dovey,Thorsten Klampfl,Cavan Bennett,Tina L. Hamilton,Dean C. Pask,Rachel Sneade,Matthew Williams,Juliet Aungier,Cedric Ghevaert,George S. Vassiliou,David G. Kent,Anthony R. Green
THROMBOSIS AND HEMOSTASIS
LETTERS TO BLOOD
BLOOD WORK
ERRATA
-
Cover Image
Cover Image
Blood-specific expression of the Srsf2 P95H mutant contributes to the myelodysplastic syndrome phenotype in transplantation settings. May-Grünwald–Giemsa staining of bone marrow cells from Srsf2 P95H mutant–transplanted mice shows dysplastic erythropoiesis. See the article by Kon et al on page 621.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals